Clinical Trial Update: Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005 [Phase 1]

View source ↗

Summary

Phase 1 multiple ascending dose study in healthy subjects evaluated the safety, tolerability, and pharmacokinetics of LY03005. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• LY03005 (LY03005)

Snippet

Sponsor: Luye Pharma Group Ltd. | Conditions: Major Depressive Disorder, Recurrent, Unspecified | Phase 1 | Status: COMPLETED